Lord, Abbett & Co
CLB icon

Lord, Abbett & Co’s Core Laboratories CLB Stock Holding History

Lord, Abbett & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-371,583
Closed -$10.7M – 649
2021
Q1 		$10.7M Sell
371,583
-3,000
-0.8% -$102K 0.03% 510
2020
Q4 		$9.9M Buy
374,583
+103,800
+38% +$2.12M 0.03% 524
2020
Q3 		$4.13M Sell
270,783
-20,300
-7% -$426K 0.01% 582
2020
Q2 		$5.92M Buy
+291,083
New +$5.22M 0.02% 554
2018
Q3 		– Sell
-267,063
Closed -$33.7M – 832
2018
Q2 		$33.7M Buy
+267,063
New +$32.5M 0.1% 332
2016
Q3 		– Sell
-124,872
Closed -$15.5M – 871
2016
Q2 		$15.5M Buy
+124,872
New +$15.1M 0.05% 468
2014
Q1 		– Sell
-27,932
Closed -$5.33M – 1010
2013
Q4 		$5.33M Buy
+27,932
New +$5.2M 0.01% 826

Other funds holding CLB

Fred Alger Management
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AKO Capital
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lord, Abbett & Co's CLB Position: Q2 2021 in Review

Lord, Abbett & Co sold out of Core Laboratories (CLB) in Q2 2021, closing a stake of 371,583 shares — an estimated $10.7M sold.

Lord, Abbett & Co first reported a position in CLB in Q4 2013 and held it in 7 quarters. The position peaked at $33.7M in Q2 2018. 195 funds tracked by Wall St. Rank hold CLB as of Q2 2021.

  • Lord, Abbett & Co reported no remaining Core Laboratories position as of Q2 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 371,583 Core Laboratories shares in Q2 2021, an estimated $10.7M.
  • Lord, Abbett & Co first reported a position in Core Laboratories in Q4 2013 and held it in 7 quarters.
  • Lord, Abbett & Co's Core Laboratories position peaked at $33.7M in Q2 2018.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2021.

Based on Lord, Abbett & Co's 13F filing for Q2 2021, filed 11 Aug 2021.